RheumaGen

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time curative cell and gene therapies.

Address

Aurora
Colorado
United States
Visit website (opens in a new tab)
Loading